Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
暂无分享,去创建一个
Qiang Zhou | Qiang Zhou | R. Yan | Yuanyuan Zhang | Yaning Li | L. Xia | Yingying Guo | Renhong Yan | Yuanyuan Zhang | Yingying Guo | Yaning Li | Lu Xia
[1] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[2] C. Yeo,et al. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? , 2020, The Lancet Gastroenterology & Hepatology.
[3] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[4] Huji Xu,et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes , 2020, bioRxiv.
[5] Christian Drosten,et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells , 2020, bioRxiv.
[6] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[7] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[8] Xin Zhao,et al. Structure of the human LAT1–4F2hc heteromeric amino acid transporter complex , 2019, Nature.
[9] Barney S. Graham,et al. Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis , 2018, Scientific Reports.
[10] Erik Lindahl,et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.
[11] Daniel Wrapp,et al. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis , 2018, Scientific Reports.
[12] Xinquan Wang,et al. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 , 2018, PLoS pathogens.
[13] F. Verrey,et al. Expression and regulation of the neutral amino acid transporter B0AT1 in rat small intestine , 2017, PloS one.
[14] D. Agard,et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.
[15] David J. Fleet,et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.
[16] E. Lindahl,et al. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2 , 2016, bioRxiv.
[17] E. Gouaux,et al. X-ray structures and mechanism of the human serotonin transporter , 2016, Nature.
[18] Kai Zhang,et al. Gctf: Real-time CTF determination and correction , 2015, bioRxiv.
[19] Nikolaus Grigorieff,et al. Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å reconstruction of rotavirus VP6 , 2015, eLife.
[20] Gary R. Whittaker,et al. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis , 2014, Virus Research.
[21] R. Henderson,et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy☆ , 2013, Ultramicroscopy.
[22] O. Jahn,et al. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2013, Journal of Virology.
[23] Eric Gouaux,et al. X-ray structure of dopamine transporter elucidates antidepressant mechanism , 2013, Nature.
[24] Stefanie Gierer,et al. Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research , 2013, Antiviral Research.
[25] Sjors H.W. Scheres,et al. RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.
[26] Sjors H.W. Scheres,et al. A Bayesian View on Cryo-EM Structure Determination , 2012, 2012 9th IEEE International Symposium on Biomedical Imaging (ISBI).
[27] Jincun Zhao,et al. A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.
[28] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[29] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[30] G. Whittaker,et al. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites , 2009, Proceedings of the National Academy of Sciences.
[31] J. Rasko,et al. A protein complex in the brush‐border membrane explains a Hartnup disorder allele , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] Leonardo G. Trabuco,et al. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. , 2008, Structure.
[33] M. Raizada,et al. ACE2: a new target for cardiovascular disease therapeutics. , 2007, Journal of cardiovascular pharmacology.
[34] R. Korstanje,et al. The emerging role of ACE2 in physiology and disease† , 2007, The Journal of pathology.
[35] S. Harrison,et al. Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.
[36] S. Diamond,et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.
[38] Joachim Frank,et al. Automated acquisition of cryo-electron micrographs for single particle reconstruction on an FEI Tecnai electron microscope. , 2005, Journal of structural biology.
[39] Q. Lin,et al. Interaction of ACE2 and integrin β1 in failing human heart , 2004 .
[40] W. Gahl,et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder , 2004, Nature Genetics.
[41] A. Bröer,et al. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19 , 2004, Nature Genetics.
[42] S. Bröer,et al. Molecular Cloning of Mouse Amino Acid Transport System B0, a Neutral Amino Acid Transporter Related to Hartnup Disorder* , 2004, Journal of Biological Chemistry.
[43] Saurabh Menon,et al. ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis , 2004, Journal of Biological Chemistry.
[44] G. Simmons,et al. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Henderson,et al. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. , 2003, Journal of molecular biology.
[46] Q. Lin,et al. Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles: Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2 , 2003, Circulation.
[47] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[48] M. Crackower,et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.
[49] Hai-yan Wang,et al. Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys* , 2001, The Journal of Biological Chemistry.
[50] M. Buchmeier,et al. Coronavirus Spike Proteins in Viral Entry and Pathogenesis , 2001, Virology.
[51] K. Robison,et al. A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.
[52] C. Shoemaker,et al. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.